Pregabalin controlled release, 165 mg

DRUG3 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions

Healthy

Phase 1

An Investigation of the Absorption and Pharmacokinetics of Multiple Doses of Three Controlled Release Pregabalin Tablets as Compared to Multiple Doses of the Immediate Release Pregabalin Capsule

CompletedNCT01009541

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2009-11-30End: 2009-12-31Updated: 2021-01-22

An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule

CompletedNCT01202422

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2010-10-31End: 2010-11-30Updated: 2021-01-22

An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers

CompletedNCT01220219

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2010-11-30End: 2011-01-31Updated: 2021-01-22